全文获取类型
收费全文 | 2085篇 |
免费 | 119篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 92篇 |
妇产科学 | 27篇 |
基础医学 | 267篇 |
口腔科学 | 37篇 |
临床医学 | 125篇 |
内科学 | 348篇 |
皮肤病学 | 19篇 |
神经病学 | 167篇 |
特种医学 | 165篇 |
外科学 | 404篇 |
综合类 | 33篇 |
预防医学 | 69篇 |
眼科学 | 33篇 |
药学 | 206篇 |
中国医学 | 5篇 |
肿瘤学 | 199篇 |
出版年
2023年 | 16篇 |
2022年 | 8篇 |
2021年 | 63篇 |
2020年 | 41篇 |
2019年 | 56篇 |
2018年 | 53篇 |
2017年 | 30篇 |
2016年 | 47篇 |
2015年 | 49篇 |
2014年 | 67篇 |
2013年 | 98篇 |
2012年 | 161篇 |
2011年 | 175篇 |
2010年 | 84篇 |
2009年 | 89篇 |
2008年 | 165篇 |
2007年 | 148篇 |
2006年 | 147篇 |
2005年 | 119篇 |
2004年 | 121篇 |
2003年 | 99篇 |
2002年 | 97篇 |
2001年 | 23篇 |
2000年 | 23篇 |
1999年 | 36篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1996年 | 7篇 |
1995年 | 14篇 |
1994年 | 5篇 |
1993年 | 11篇 |
1992年 | 22篇 |
1991年 | 17篇 |
1990年 | 21篇 |
1989年 | 22篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 6篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1970年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有2221条查询结果,搜索用时 187 毫秒
1.
2.
Bruno Emond Murali Sundaram Hela Romdhani Patrick Lefebvre Song Wang Anthony Mato 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(12):763-775.e2
BackgroundStudies assessing ibrutinib’s economic burden versus chemoimmunotherapy (CIT) focused on pharmacy costs but not medical costs. This study compared time to next treatment (TTNT), health care resource utilization (HRU), and total direct costs among patients with chronic lymphocytic leukemia (CLL) initiating front-line ibrutinib single agent (Ibr) or CIT.Materials and MethodsOptum Clinformatics Extended DataMart De-Identified Databases were used to identify adults with ≥ 2 claims with a CLL diagnosis initiating front-line Ibr or CIT from February 12, 2014 to June 30, 2017. Inverse probability of treatment weighting was used to control for potential differences in baseline characteristics between the Ibr and CIT cohorts. Two periods were considered: entire front-line therapy (until initiation of second-line therapy) and first 6 months of front-line therapy. Comparisons with a subgroup of CIT patients initiating bendamustine/rituximab (BR) were also conducted.ResultsTTNT was significantly longer for Ibr (N = 322) relative to CIT (N = 839; hazard ratio, 0.54; P = .0163; Kaplan-Meier rates [24 months]: Ibr = 88.6%, CIT = 75.9%) and the subset of CIT patients treated with BR (N = 455; hazard ratio, 0.54; P = .0208; Kaplan-Meier rates [24 months]: Ibr = 89.0%, BR = 79.0%). During the entire front-line therapy, Ibr patients had significantly fewer monthly days with outpatient visits (rate ratio = 0.75; P = .0200). Ibrutinib’s higher pharmacy costs (mean monthly cost difference [MMCD] = $6,849; P < .0001) were offset by lower medical costs (MMCD = ?$10,615; P < .0001), yielding net savings (MMCD = ?$3,766; P < .0001) versus CIT. Ibr was associated with net savings (MMCD = ?$5,569; P < .0001) versus BR. Cost savings and reductions in HRU were more pronounced during the first 6 months of front-line therapy.ConclusionDuring front-line CLL treatment, Ibr was associated with longer TTNT, fewer monthly days with outpatient visits, and net monthly total cost reduction versus CIT and BR. 相似文献
3.
Venkatesan Chakrapani Thilakavathi Subramanian Pandara Purayil Vijin Ruban Nelson Murali Shunmugam Trace Kershaw 《Global public health》2020,15(3):438-451
ABSTRACTHIV-positive men who have sex with men (HIV+MSM) in India need culturally-relevant interventions to promote safer sex. We tested a multi-level intervention among HIV+MSM that targeted individual, interpersonal, and community factors, based on the Social-Personal and Social Ecological Models. We conducted a 2?×?2 factorial RCT with 119 HIV+MSM randomised to receive either an individual-level intervention (ILI) using motivational interviewing to promote safer sex, a community-level intervention (CLI) to strengthen community norms toward safer sex and reduce stigma among MSM communities, a multi-level intervention combining the individual- and community-level interventions (ILI?+?CLI), or standard-of-care control. Participants completed pre- and post-intervention assessments of a composite sexual risk score and a process evaluation to assess fidelity and satisfaction. Out of the 119 HIV+MSM, 106 (89.0%) completed pre- and post-intervention assessments. Generalised Estimating Equation models showed that both CLI (Incidence Rate Ratio [IRR]?=?.67, 95% CI .47 to .96) and ILI?+?CLI (IRR?=?.66, 95% CI .48 to .91) groups had a statistically significant decrease in sexual risk compared to the standard-of-care. The interventions had high levels of fidelity and satisfaction. This pilot RCT demonstrated feasibility and potential effectiveness of a multi-level intervention that addresses individual, interpersonal and community-level contributors of sexual risk among HIV+MSM. 相似文献
4.
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists 下载免费PDF全文
Daniel M Berney Ferran Algaba Mahul Amin Brett Delahunt Eva Compérat Jonathan I Epstein Peter Humphrey Mohammed Idrees Antonio Lopez‐Beltran Cristina Magi‐Galluzzi Gregor Mikuz Rodolfo Montironi Esther Oliva John Srigley Victor E Reuter Kiril Trpkov Thomas M Ulbright Murali Varma Clare Verrill Robert H Young Ming Zhou Lars Egevad 《Histopathology》2015,67(3):313-324
5.
Heitzer Andrew M. Villagran Alexandra M. Raghubar Kimberly Brown Austin L. Camet Miranda L. Ris M. Douglas Hanning Jenny H. Okcu M. Fatih Paulino Arnold C. Chintagumpala Murali Kahalley Lisa S. 《Journal of neuro-oncology》2020,146(1):147-156
Journal of Neuro-Oncology - Survivors of pediatric embryonal brain tumors (BT) are at high risk for sensorineural hearing loss (SNHL) associated with neurocognitive decline. However, previous... 相似文献
6.
7.
8.
Bach Quang Le Bina Rai Zophia Xue Hui Lim Tuan Chun Tan Tingxuan Lin Jaslyn Jie Lin Lee Sadasivam Murali Swee Hin Teoh Victor Nurcombe Simon McKenzie Cool 《Journal of cranio-maxillo-facial surgery》2019,47(2):341-348
Background
Cranioplasty is a surgical procedure used to treat a bone defect or deformity in the skull. To date, there is little consensus on the standard-of-care for graft materials used in such a procedure. Graft materials must have sufficient mechanical strength to protect the underlying brain as well as the ability to integrate and support new bone growth. Also, the ideal graft material should be individually customized to the contours of the defect to ensure a suitable aesthetic outcome for the patient.Purpose
Customized 3D-printed scaffolds comprising of polycaprolactone-β-tricalcium phosphate (PCL-TCP) have been developed with mechanical properties suitable for cranioplasty. Osteostimulation of PCL-TCP was enhanced through the addition of a bone matrix-mimicking heparan sulphate glycosaminoglycan (HS3) with increased affinity for bone morphogenetic protein-2 (BMP-2). Efficacy of this PCL-TCP/HS3 combination device was assessed in a rat critical-sized calvarial defect model.Method
Critical-sized defects (5 mm) were created in both parietal bones of 19 Sprague Dawley rats (Male, 450–550 g). Each cranial defect was randomly assigned to 1 of 4 treatment groups: (1) A control group consisting of PCL-TCP/Fibrin alone (n = 5); (2) PCL-TCP/Fibrin-HSft (30 μg) (n = 6) (HSft is the flow-through during HS3 isolation that has reduced affinity for BMP-2); (3) PCL-TCP/Fibrin-HS3 (5 μg) (n = 6); (4) PCL-TCP/Fibrin-HS3 (30 μg) (n = 6). Scaffold integration and bone formation was evaluated 12-weeks post implantation by μCT and histology.Results
Treatment with PCL-TCP/Fibrin alone (control) resulted in 23.7% ± 1.55% (BV/TV) of the calvarial defect being filled with new bone, a result similar to treatment with PCL-TCP/Fibrin scaffolds containing either HSft or HS3 (5 μg). At increased amounts of HS3 (30 μg), enhanced bone formation was evident (BV/TV = 38.6% ± 9.38%), a result 1.6-fold higher than control. Further assessment by 2D μCT and histology confirmed the presence of enhanced bone formation and scaffold integration with surrounding host bone only when scaffolds contained sufficient bone matrix-mimicking HS3.Conclusion
Enhancing the biomimicry of devices using a heparan sulphate with increased affinity to BMP-2 can serve to improve the performance of PCL-TCP scaffolds and provides a suitable treatment for cranioplasty. 相似文献9.
10.
Dr Evan D. Kharasch MD PhD Murali Sivarajan MB BS 《Journal of clinical monitoring and computing》1991,7(2):172-174
Metered dose inhalers containing halogenated propellants may interfere with mass spectrometer quantitation of halogenated inhalation anesthetics. We identify the propellant(s) in a commercially available metered dose inhaler that caused erroneous mass spectrometer readings. In addition, we identify the causes of different types of interference in different mass spectrometers. 相似文献